库珀医疗CooperCompanies（COO）2026财年第一季度财报（10-Q）「NYSE」（英文版）（33页）.pdf

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549_FORM 10-Q_Quarterly Report Pursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934For the quarterly period ended January 31,2026Transition Report Pursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934For

2、 the transition period from to Commission File Number 1-8597_The Cooper Companies,Inc.(Exact name of registrant as specified in its charter)_Delaware94-2657368(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)6101 Bollinger Canyon Road,Suite 500,San Ram

3、on,California 94583(Address of principal executive offices)(Zip Code)(925)460-3600(Registrants telephone number,including area code)_Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading SymbolName of each exchange on which registeredCommon Stock,$0.10 par valueCOONasd

4、aq Global Select MarketIndicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has bee

5、n subject to such filingrequirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T(232.405 of this chapter)during the preceding 12 months(or for such sh

6、orter period that the registrant was required to submit suchfiles).Yes No Indicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,a smaller reporting company,or anemerging growth company.See the definitions of“large accelerated filer,”“